Sage Therapeutics Net Tangible Assets

Sage Therapeutics (SAGE) currently reports a net tangible assets of $370M as of June 2025. That compares with $630M in the prior-year period — down 41.3% year over year. Use the charts on this page to explore Sage Therapeutics's net tangible assets history and peer comparisons.

Sage Therapeutics's net tangible assets decreased from $630M to $370M — a 41.3% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sage Therapeutics reported $370M in net tangible assets as of June 2025. That compares with $630M in the prior-year period — down 41.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $370M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sage Therapeutics, and consider following SAGE for alerts when major investors trade the stock.

Sage Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $370M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SAGE with unrelated industries.